Avadel Pharmaceuticals Plc (AVDL)
21.53
+0.02
(+0.09%)
USD |
NASDAQ |
Jan 22, 16:00
21.54
+0.01
(+0.05%)
After-Hours: 20:00
Avadel Pharmaceuticals Research and Development Expense (TTM): 39.89M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alkermes Plc | 283.30M |
| Jazz Pharmaceuticals Plc | 809.33M |
| Medtronic Plc | 2.839B |
| STERIS Plc (Ireland) | 109.64M |
| Amarin Corp. Plc | 17.36M |